China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Value of Targeted Fibroblast Activation Protein FAPI PET/MR in Precision Diagnosis and Treatment of Gastric Cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133549
Registration Time: 2026/09/29
Type: Diagnostic test
Primary Sponsor: Zhejiang Cancer Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345236
Published by HT Digital Content Services with permission from Health Daily Digest....